Beijing-based growth equity investor Oceanpine Capital has held the final closing of its second US dollar fund, Oceanpine DeepTech Fund, at $400 million to make new bets on deeptech and innovative growth-stage companies in China’s TMT and biotech sectors.
Limited partners (LPs) in the final closing included Oceanpine’s management team and other global institutional investors, mainly from the US and Asia, including insurance firms, entrepreneurs & founders of technology companies (mostly listed), asset managers, family offices, and venture capitalists, said the firm in a WeChat post on Wednesday.
